| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Medicine > Lighting - UV Light to Treat Psoriasis |
|
E-Articles - Lighting - UV Light to Treat Psoriasis
Light therapy is a clear proof that the role of lighting goes beyond what we normally understand using this term. Usually, when we say lighting we thi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nk illumination or light effects, or accent lighting. We rarely associate the term with a form of therapy, but light is used to treat various illnesse ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s and it works; more or less. Light, in its different colors and form) is used to treat acne, eczema and psoriasis, sleep related disorders, depressio lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. n (seasonal or non-seasonal) and it is believed to relieve even pain. Now let's take a look at a paradox: the harmful UV light is used to treat psoria here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is. The use of UV lighting to treat severe skin conditions is called phototherapy. One of the most severe skin conditions treated with ultra violet l d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ight is psoriasis. This is a very common skin disease, with many variations from psoriasis vulgaris (which is the most common form) to inverse psorias ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is. The illness affects people of all ages, women and men with equal frequency. It is not transmissible; it occurs usually in the second decade of li easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e and might remain a lifelong companion. The symptoms include irregular fingernail growth, raised and inflamed red lesions on the skin, covered with l nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ayers of dead skin cells and rarely, arthritis. There is no cure for the disease, but there are some treatment options that could control the developm and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ent of the skin lesions. Among them, use of UV lighting devices. As you already know, UV light is harmful. There are three types of UV light: A, B a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d C. While UVC doesn't exist in its pure form in nature (the waves coming from the sun are getting absorbed in the atmosphere) UVB and UVA are present ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a , yet not in sufficient amounts for people suffering from psoriasis. Too much of that light and we'll suffer too, for UV light might cause skin cancer dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod , premature aging of the skin, cataracts and other problems, including DNA damage. For the synthesis of vitamin D, we need UV-A, the least harmful of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin the three, but how does UV light help with psoriasis? Simple: it slows down the production of skin cells, thus helping to reduce inflammation. This i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the very reason why overexposure causes skin disorders. Therefore, it is clear that UV light therapy should never be practiced in the absence of trai t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ned medics. The UVA light therapy method use to treat psoriasis is called PUVA. It combines psoralen and ultraviolet A. It is efficient on almost 85 ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust % of the patients suffering from minor to medium forms of the disease. A number of 20-30 minute treatments are needed to start seeing obvious results y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Too much UVA light and patients might experience adverse effects including nausea and burning. UV-B is used alone or in combination with medicine. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de For example, the most popular form of treatment that employs UV-B is the Goeckerman regimen (UV-B plus coal tar). Other treatments are the Ingram meth elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip od (which involves applying anthralin after a tar bath and UV-B light therapy) and a combination of UV-B with corticosteroids or other softening creams tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|